Filing Details

Accession Number:
0001127602-19-030598
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-16 16:02:47
Reporting Period:
2019-10-15
Accepted Time:
2019-10-16 16:02:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492422 Apellis Pharmaceuticals Inc. APLS Pharmaceutical Preparations (2834) 271537290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658080 Cedric Francois C/O Apellis Pharmaceuticals, Inc
6400 Westwind Way, Suite A
Crestwood KY 40014
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-15 1,476 $25.59 1,020,317 No 4 S Direct
Common Stock Disposition 2019-10-15 3,524 $26.61 1,016,793 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 234,411 Indirect See Footnote
Footnotes
  1. Scheduled sale from 10B5-1 trading plan.
  2. Average Sale Price: Min. $25.02 Max. $25.96
  3. Average Sale Price: Min. $26.18 Max. $27.09
  4. The securities are held by The Francois-DuBois Educational Trust (the "Trust"), for which Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.